Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

SM-130686 vs MK-677 (Ibutamoren) — Peptide Comparison

SM-130686 vs MK-677 (Ibutamoren) — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

At a Glance

Quickcomparison

Dose Range

SM-130686

5–20 mg

MK-677 (Ibutamoren)

10–25 mg

Frequency

Multiple times daily

Once daily

Administration

Oral capsule or powder

Oral (capsule or liquid)

Cycle Length

8-12 weeks

Onset Speed

Moderate (1-2 weeks)

Evidence Level

Moderate human trials (Phase 1-2)

Efficacy

Benefitratings

Muscle and Strength

Recovery and Performance

Metabolic Health

Muscle and body composition

Recovery and athletic performance

Sleep quality and metabolic health

Technical Data

Compoundspecifications

Molecular Formula

C22H24Cl2F3N3O3

Molecular Weight

506.3 g/mol (as HCl salt)

Half-Life

Not published in humans (preclinical only)

Bioavailability

28% in rats (oral administration)

CAS Number

259667-25-9

C27H36N4O5S

528.7 g/mol

4-6 hours (IGF-1 elevation persists ~24 hours)

High oral bioavailability

159634-47-6

Protocols

Dosingtiers

starting

10 mg

2-4 weeks initial

Lower entry dose used in practice to limit water retention and appetite surge before titrating up.

standard

25 mg

Studied up to 1-2 years

25 mg once-daily oral is the dose used in the randomized trial in healthy older adults; increased GH/IGF-1 and fat-free mass [1]. Most-studied dose [2].

Applications

Bestsuited for

Lean Mass Building in Trained Athletes

SM-130686 targets GHS-R to stimulate GH release, which supports anabolic processes. Preclinical studies in rats showed significant increases in fat-free mass and body weight when combined with resistance training principles.

Age-Related GH Decline

As a GHS-R agonist, SM-130686 may help restore physiological GH secretion in adults experiencing age-related decline. The oral route is convenient for long-term administration.

GH supports tissue repair, collagen synthesis, and recovery. May benefit individuals engaged in intensive resistance training or athletic performance work.

Older Adults (60+) Seeking Body Composition Improvements

MK-677 was designed for aging populations. It restores GH and IGF-1 to youthful levels, increases lean mass, and improves physical function in people over 60. A 2-year clinical trial showed a 1.1 kg gain in fat-free mass with only modest fat gain—ideal for maintaining strength in older age.

Athletes and Fitness Enthusiasts Wanting Recovery Support

Oral dosing makes MK-677 convenient for athletes. It enhances muscle protein synthesis, speeds recovery after intense training, and supports lean mass building without the hassle of injections.

People with Chronic Wasting or Protein Deficiency

Clinical trials show MK-677 helps treat protein-energy wasting in kidney disease and other conditions. It stimulates appetite (a feature in these populations) and preserves muscle tissue—making it useful for those losing mass despite good nutrition.

Safety Profile

Sideeffects

Common

Appetite stimulation

Transient water retention

Uncommon

Joint or muscle aches

Transient changes in blood glucose

Serious

Potential carpal tunnel syndrome

Unknown effects on tumor growth

Increased appetite

Mild water retention or edema

Elevated fasting glucose

Joint or muscle pain

Carpal tunnel syndrome or nerve compression symptoms

Mild nausea or digestive upset

Glucose dysregulation and diabetes risk

Research Status

Safety& evidence

FDA Status

Research compound

Safety Overview

SM-130686 is a research compound that has never been tested in humans. All safety and efficacy data come from animal studies (primarily rats). No human clinical trials have been conducted. Use carries unknown risks. Potential side effects based on GH physiology and limited preclinical work.

Contraindications

xPregnancy or breastfeeding (no safety data)

xActive cancer (GH stimulation may be contraindicated)

xUncontrolled diabetes (may affect glucose metabolism)

xSevere cardiovascular disease (GH effects on heart not fully characterized)

MK-677 has been studied in hundreds of humans over 2+ years and is generally well tolerated. Most side effects are mild and manageable, especially with lower starting doses. The lack of injection requirement makes it safer than injectable GH in terms of infection risk and sterility concerns. However, it is not FDA approved and should be viewed as a research compound.

xUncontrolled diabetes or severe glucose dysregulation

xActive cancer or high cancer risk requiring caution with IGF-1 elevation

xPregnancy or breastfeeding

Decision Guide

Which isright for you?

Choose SM-130686 if...

Lean mass building (theoretical)

Strength development (preclinical evidence)

Body composition improvement (animal studies)

Choose MK-677 (Ibutamoren) if...

Building lean muscle mass and strength

Improving overall body composition in aging adults

Enhancing athletic recovery and performance

Supporting metabolic health and fat loss

Connected topics

Follow this recovery question